Another MS Drug Class Causes Concern for COVID Vaccine Protection

— Vaccine effectiveness may be reduced in MS patients on S1P modulators, data suggest Multiple sclerosis (MS) patients treated with cladribine (Mavenclad) or teriflunomide (Aubagio) had appropriate humoral response against SARS-CoV-2 a month after vaccination, but...

Multiple sclerosis linked to infection in adolescence – new study

Multiple sclerosis (MS) is most often diagnosed between the ages of 20 and 50. Certain genes put a person at greater risk of getting this disease of the central nervous system, but scientists are still trying to understand the triggers. My colleagues and I have been...

Foods to Avoid for Managing Multiple Sclerosis

Multiple sclerosis is a chronic ailment affecting the central nervous system. In this condition, the immune system starts attacking the protective layer of the nerve tissues, causing inflammation in and damage to tissues and lesions. This, in turn, can affect the...

When Multiple Sclerosis Causes Skin Symptoms

Damage to the brain and spinal cord can cause a variety of abnormal sensations in the skin. However, the sensations actually have nothing to do with the skin. Virtually all symptoms of multiple sclerosis (MS) are a result of the damage MS does to the brain and spinal...

How to Spot the Signs of an MS Flare

More than two-thirds of the approximately 1 million people with multiple sclerosis (MS) in the United States have relapsing-remitting MS (RRMS), which means they have periods when their symptoms are severe — relapses — and periods when their symptoms are less severe,...

How Age Affects Multiple Sclerosis Symptoms and Progression

Most people with multiple sclerosis (MS) are diagnosed between age 20 and 50, though it can occur in children as well as in older adults, according to the National Multiple Sclerosis Society (NMSS). About 85 percent of people diagnosed with MS are initially diagnosed...